BioSpace News Archive

PharmaMar (MSE:PHM) is taking part in the 10th China Healthcare Investment Conference (CHIC) in Shanghai, China, from 26th to 28th March.

Dutch biotechnology company Micreos announced it has secured €30 million in funding to accelerate the development of its endolysin technology, set to replace antibiotics.

CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced financial results for the full year ended December 31, 2018 and provided an overview of recent accomplishments and plans for its research and development programs.

With the rising popularity of holistic dentistry and the advent of Accountable Care Organizations (ACO’s), dental professionals are encouraged, and even incentivized to provide a wider range of prevention focused products and services.

The March issue of The American Journal of Managed Care® (AJMC®) focuses on the impact of Medicaid across the country, including challenges with access to specialists, the association of fragmented care with later emergency department visits, difficulties in having a usual source of care in an urban area with many providers, and more.

Tufts Health Plan received a perfect score on the 2019 Corporate Equality Index, the nation’s premier benchmarking survey and report on corporate policies and practices related to LGBTQ workplace equality, administered by the Human Rights Campaign Foundation.

American Water Works Company, Inc. (NYSE: AWK), the largest publicly traded U.S. water and wastewater utility company, announced today it was recently awarded $480,000 from the Water Research Foundation (WRF), to define a framework for the water industry to monitor for opportunistic pathogens, including Legionella, the bacteria that can cause a form of pneumonia known as Legionnaires disease.

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that it has commenced a strategic review of its branded product portfolio, as well as its roster of international partners

Advaxis, Inc. announces the presentation of ADXS-NEO data in a poster discussion entitled “Safety and Immunogenicity of a Personalized Neoantigen-Listeria Vaccine in Cancer Patients” at the American Association for Cancer Research (AACR) Annual Meeting underway in Atlanta.

Eisai Co., Ltd. announced that in the 8th meeting of the Data Safety Monitoring Board for the global Phase III clinical studies on the investigational oral BACE inhibitor elenbecestat in early Alzheimer’s disease, the DSMB reviewed safety data including the potential for decline in cognition, and recommended the continuation of the studies.